Suppliers in Menomonee Falls, WI
17 Medicare Suppliers found. Showing 1 - 17
 Cvs Pharmacy #04996 Durable Medical Equipment & Medical Supplies Location: N83w15550 Appleton Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 253-5056 |
Cvs Pharmacy #16301 Durable Medical Equipment & Medical Supplies Location: N95 W 17707 Shady Ln, Menomonee Falls, Wisconsin 53051 Phone: (262) 415-0005 |
Cvs Pharmacy # 03108 Durable Medical Equipment & Medical Supplies Location: W 165 N 5595 Creekwood Crossing, Menomonee Falls, Wisconsin 53051 Phone: (262) 703-3386 |
Walgreens #5002 Durable Medical Equipment & Medical Supplies Location: N83w15701 Appleton Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-3890 |
Walgreens #07143 Durable Medical Equipment & Medical Supplies Location: N56w15501 Silver Spring Dr, Menomonee Falls, Wisconsin 53051 Phone: (262) 703-9781 |
Aurora Pharmacy Inc. Clinic Pharmacy Location: N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-8500 |
Pick 'n Save Pharmacy #6892 Pharmacy Location: N95w18351 County Line Rd, Menomonee Falls, Wisconsin 53051 Phone: (262) 253-4705 |
Pick 'n Save Pharmacy #6377 Community/Retail Pharmacy Location: N77w14435 Appleton Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 255-7598 |
Aurora Health Center Durable Medical Equipment & Medical Supplies Location: N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-7500 |
Cork Medical Medicare Supplier Location: W134n5514 Campbell Dr, Menomonee Falls, Wisconsin 53051 Phone: (317) 361-4554 |
Froedtert Home Infusion Therapy Pharmacy Location: N86w12999 Nightingale Way, Menomonee Falls, Wisconsin 53051 Phone: (262) 532-5124 |
Wisconsin Vision Inc Medicare Supplier Location: N85 W16033 Appleton Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-1900 |
Aurora Vision Center-menomonee Fall Eyewear Supplier (Equipment, not the service) Location: N84w16889 Menomonee Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-2299 |
Visionworks Eyewear Supplier (Equipment, not the service) Location: N 95 W 18437 County Line Rd, Menomonee Falls, Wisconsin 53051 Phone: (262) 532-0570 |
Good Hope Vision Center Sc Medicare Supplier Location: N72w13400 Lund Ln, Menomonee Falls, Wisconsin 53051 Phone: (262) 208-1344 |
Lenscrafters #5617 Eyewear Supplier (Equipment, not the service) Location: N95w18161 Appleton Ave, Menomonee Falls, Wisconsin 53051 Phone: (262) 251-1378 |
Bioresolutions Llc Durable Medical Equipment & Medical Supplies Location: N56w16688 Ridgewood Dr, Menomonee Falls, Wisconsin 53051 Phone: (262) 820-0289 |
News Archive
AAPS honors Morphotek with 2012 Excellence in Ligand Binding Assays Award
Morphotek, Inc., a subsidiary of Eisai Inc., announced today that The American Association of Pharmaceutical Scientists (AAPS) has awarded its 2012 Excellence in Ligand Binding Assays Award to the Bioanalytical Development group from Morphotek for their abstract, "Development and Validation of a Pharmacokinetic Assay on the Gyrolab Platform for Use in Phase II/III Clinical Studies."
Erye's new facility passes SFDA inspection for manufacture of penicillin, cephalosporin powder
NeoStem, Inc., an international biopharmaceutical company with operations in the U.S. and China, announced on June 15, 2010 that its 51% owned Suzhou Erye pharmaceutical subsidiary passed the government inspection by the State Food and Drug Administration ("SFDA") in China to manufacture penicillin and cephalosporin powder for injection at its new manufacturing facility.
Younger women more likely to experience one-year adverse cardiovascular events after PCI
Women younger than 55 years of age who undergo percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) are more likely to experience one-year adverse cardiovascular events due to risk factors such as diabetes and chronic kidney disease, yet they are less likely to receive potent antiplatelet therapy than men. The PROMETHEUS study found that outcomes for both men and women post-PCI are dependent on their baseline risk factors, not their sex.
U.S. FDA agrees to the study design for cardiovascular outcomes trial of alogliptin
Takeda Pharmaceutical Company Limited ("Takeda") and Takeda Global Research & Development Center, Inc., a wholly owned United States (U.S.) subsidiary, today jointly announced that the latter has received notification that the U.S. Food and Drug Administration (FDA) has agreed to the study design for a cardiovascular (CV) outcomes trial titled EXAMINE (EXamination of CArdiovascular OutcoMes: AlogliptIN vs. Standard of CarE in Patients with Type 2 Diabetes Mellitus and Acute Coronary Syndrome) for alogliptin, a selective dipeptidyl peptidase IV inhibitor under investigation for the treatment of type 2 diabetes as an adjunct to diet and exercise.
› Verified 5 days ago